Point of Care Tests in the Management of Very Early Medical Abortion

NCT07417787 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2026-04-07

No results posted yet for this study

Summary

This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \<6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.

Conditions

  • Abortion Early

Interventions

DIAGNOSTIC_TEST

Blood test

Patients will undergo one additional blood test than is usual with standard care, to measure Human Chorionic Gonadotropin (HCG) level which will be analysed on a point of care test machine and in the lab

OTHER

Participant Questionnaire

The investigators will administer participant questionnaires to both staff and patients to understand opinions on the point of care test machine

Sponsors & Collaborators

  • NORDIC pharma (funding)

    collaborator UNKNOWN
  • NHS Lothian

    collaborator OTHER_GOV
  • Karolinska Institutet

    collaborator OTHER
  • Karolinska University Hospital

    collaborator OTHER
  • Göteborg University

    collaborator OTHER
  • Sahlgrenska University Hospital

    collaborator OTHER
  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Sharon Cameron · NHS Lothian

  • John Reynolds-Wright · University of Edinburgh

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-23
Primary Completion
2027-02-28
Completion
2028-02-29

Countries

  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07417787 on ClinicalTrials.gov